We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$56M
Cap. Flow
-$6.27M
Cap. Flow %
-2.51%
Top 10 Hldgs %
51.39%
Holding
108
New
15
Increased
21
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.19M
2
MU icon
Micron Technology
MU
+$1.73M
3
C icon
Citigroup
C
+$1.45M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$1.1M
5
AMGN icon
Amgen
AMGN
+$818K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.95M
2
AAPL icon
Apple
AAPL
+$2.23M
3
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.15M
4
GLD icon
SPDR Gold Trust
GLD
+$916K
5
BHVN icon
Biohaven
BHVN
+$805K

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.91%
2 Healthcare 26.92%
3 Technology 16.18%
4 Communication Services 7.16%
5 Consumer Discretionary 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
51
PUT
Oracle
ORCL
$455B
$1.02M 0.41%
+6,000
New +$869K
ZLAB icon
52
Zai Lab
ZLAB
$2.88B
$1.02M 0.41%
42,250
+11,800
+39% +$223K
PFE icon
53
Pfizer
PFE
$158B
$994K 0.4%
34,350
-900
-3% -$26.3K
OI icon
54
O-I Glass
OI
$965M
$974K 0.39%
74,250
-16,500
-18% -$198K
STEW
55
SRH Total Return Fund
STEW
$1.75B
$932K 0.37%
59,000
– –
GDXJ icon
56
VanEck Junior Gold Miners ETF
GDXJ
$9.19B
$927K 0.37%
19,000
+5,300
+39% +$244K
MRVL icon
57
Marvell Technology
MRVL
$217B
$902K 0.36%
12,500
-5,000
-29% -$345K
AVGO icon
58
Broadcom
AVGO
$1.67T
$863K 0.34%
5,000
-4,750
-49% -$762K
EVO icon
59
Evotec
EVO
$593M
$792K 0.32%
217,055
+102,102
+89% +$405K
BNED icon
60
Barnes & Noble Education
BNED
$372M
$782K 0.31%
84,500
+7,000
+9% +$72.2K
PYPL icon
61
PayPal
PYPL
$45.4B
$780K 0.31%
10,000
-1,000
-9% -$66.9K
BUR icon
62
Burford Capital
BUR
$898M
$690K 0.28%
52,000
– –
SNY icon
63
Sanofi
SNY
$103B
$634K 0.25%
11,000
– –
BA icon
64
Boeing
BA
$158B
$631K 0.25%
4,150
-500
-11% -$85.7K
TEVA icon
65
CALL
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
$604K 0.24%
33,500
+18,500
+123% +$324K
GDX icon
66
PUT
VanEck Gold Miners ETF
GDX
$29B
$597K 0.24%
+15,000
New +$568K
FLUT icon
67
Flutter Entertainment
FLUT
$16.7B
$593K 0.24%
2,500
-700
-22% -$145K
EEM icon
68
iShares MSCI Emerging Markets ETF
EEM
$31.1B
$573K 0.23%
12,500
– –
NAMS icon
69
NewAmsterdam Pharma
NAMS
$2.61B
$564K 0.23%
+34,000
New +$588K
AMZN icon
70
CALL
Amazon
AMZN
$2.72T
$559K 0.22%
3,000
– –
BIDU icon
71
PUT
Baidu
BIDU
$30.7B
$526K 0.21%
+5,000
New +$442K
TDOC icon
72
Teladoc Health
TDOC
$1.17B
$482K 0.19%
52,500
– –
ARQ icon
73
Arq
ARQ
$90.8M
$429K 0.17%
73,000
+51,000
+232% +$311K
RPRX icon
74
Royalty Pharma
RPRX
$26.1B
$424K 0.17%
+15,000
New +$415K
BIDU icon
75
CALL
Baidu
BIDU
$30.7B
$421K 0.17%
+4,000
New +$353K
1 2
3
4 5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, DCF Advisers held 108 positions worth $250M, up 29% from $194M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers's Q3 2024 filing shows 15 new, 21 increased, 34 reduced and 11 closed positions. Its largest new stake was NewAmsterdam Pharma: 34,000 shares worth $564K. The largest sale was Regeneron Pharmaceuticals, an estimated $2.95M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • DCF Advisers's largest Q3 2024 buy was NewAmsterdam Pharma: 34,000 shares worth $564K.
  • DCF Advisers added most to Amazon in Q3 2024, an estimated $3.19M increase.
  • DCF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $2.95M.
  • DCF Advisers fully exited Snowflake in Q3 2024, selling an estimated $439K.
  • DCF Advisers's ten largest holdings make up 51% of its $250M portfolio in Q3 2024.
  • DCF Advisers opened 15 new positions and closed 11 in Q3 2024.
  • DCF Advisers's portfolio value rose 29% quarter-over-quarter to $250M.

Based on DCF Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.